Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Price

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|March 6, 2007
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonA Ratcliff, H Siswantoro, E Kenangalem, et al.
BMJ Open|August 21, 2014
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)M J Grigg, T William, P Dhanaraj, et al.
The American Journal of Tropical Medicine and Hygiene|April 13, 2000
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malariaM Van Vugt, B J Angus, R N Price, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 10, 2006
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, IndonesiaA Ratcliff, H Siswantoro, E Kenangalem, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Determinants of in vitro drug susceptibility testing of Plasmodium vivaxB Russell, F Chalfein, B Prasetyorini, et al.
Epidemics|June 22, 2023
A model for malaria treatment evaluation in the presence of multiple speciesC R Walker, R I Hickson, E Chang, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, IndonesiaH Siswantoro, B Russell, A Ratcliff, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malariaR N Price, A R Hasugian, A Ratcliff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malariaA R Hasugian, H L E Purba, E Kenangalem, et al.
The Journal of Infectious Diseases|September 24, 2008
Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxR Suwanarusk, M Chavchich, B Russell, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|March 6, 2007
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonA Ratcliff, H Siswantoro, E Kenangalem, et al.
BMJ Open|August 21, 2014
A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial)M J Grigg, T William, P Dhanaraj, et al.
The American Journal of Tropical Medicine and Hygiene|April 13, 2000
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malariaM Van Vugt, B J Angus, R N Price, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 10, 2006
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, IndonesiaA Ratcliff, H Siswantoro, E Kenangalem, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Determinants of in vitro drug susceptibility testing of Plasmodium vivaxB Russell, F Chalfein, B Prasetyorini, et al.
Epidemics|June 22, 2023
A model for malaria treatment evaluation in the presence of multiple speciesC R Walker, R I Hickson, E Chang, et al.
Antimicrobial Agents and Chemotherapy|October 13, 2010
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, IndonesiaH Siswantoro, B Russell, A Ratcliff, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malariaR N Price, A R Hasugian, A Ratcliff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malariaA R Hasugian, H L E Purba, E Kenangalem, et al.
The Journal of Infectious Diseases|September 24, 2008
Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxR Suwanarusk, M Chavchich, B Russell, et al.
Pageof 4